Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

JHONSUA ALBERTO JIMENEZ ARIAS MEDICAL PLLC

NPI: 1760124036 · NEW YORK, NY 10031 · Family Medicine Physician · NPI assigned 04/08/2022

$96K
Total Medicaid Paid
30,476
Total Claims
29,857
Beneficiaries
56
Codes Billed
2022-12
First Month
2024-12
Last Month

Provider Details

Authorized OfficialJIMENEZ ARIAS, JHONSUA (OWNER/AUTHORIZED OFFICIAL)
NPI Enumeration Date04/08/2022

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2022 574 $381.77
2023 16,649 $41K
2024 13,253 $55K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2,858 2,734 $31K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 736 730 $29K
G0444 Annual depression screening, 5 to 15 minutes 1,372 1,367 $14K
99385 320 320 $8K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 489 489 $7K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 238 238 $4K
93000 547 546 $995.99
99386 101 101 $590.37
36415 Collection of venous blood by venipuncture 2,237 2,222 $261.88
83036 Hemoglobin; glycosylated (A1C) 355 355 $198.51
99497 27 26 $179.14
G8510 Screening for depression is documented as negative, a follow-up plan is not required 167 167 $140.00
80061 Lipid panel 255 255 $132.45
3074F 2,116 2,043 $110.00
99397 62 62 $105.07
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 14 14 $90.46
3078F 1,190 1,144 $60.00
81002 674 674 $57.44
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory 12 12 $48.17
3079F 1,297 1,273 $40.00
87270 216 216 $12.16
84132 439 439 $10.71
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 439 439 $10.00
82565 442 442 $7.62
A4556 Electrodes, (e.g., apnea monitor), per pair 358 358 $6.19
H0001 Alcohol and/or drug assessment 225 223 $4.00
85025 Blood count; complete (CBC), automated, and automated differential WBC count 219 219 $2.40
3511F 313 313 $0.00
1160F 730 721 $0.00
3725F 1,067 1,063 $0.00
1159F 744 735 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 463 452 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 1,012 968 $0.00
0521F 1,413 1,371 $0.00
4013F 59 59 $0.00
3077F 73 69 $0.00
99401 515 515 $0.00
3015F 19 19 $0.00
G9507 Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) 16 16 $0.00
1158F 14 13 $0.00
1000F 682 681 $0.00
G8473 Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed 229 224 $0.00
3351F 102 101 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 1,119 1,078 $0.00
3008F 2,468 2,365 $0.00
1125F 1,166 1,132 $0.00
3075F 195 192 $0.00
82270 81 81 $0.00
1123F 13 12 $0.00
1126F 137 136 $0.00
G8419 Bmi documented outside normal parameters, no follow-up plan documented, no reason given 62 62 $0.00
G8418 Bmi is documented below normal parameters and a follow-up plan is documented 69 66 $0.00
4010F 226 222 $0.00
3014F 12 12 $0.00
3017F 59 59 $0.00
1170F 13 12 $0.00